1 |
Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsy S, Pesavento T. De novo thrombotic microangiopapthy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant 2010;10:1804-11.
DOI
ScienceOn
|
2 |
Ashman N, Chapagain A, Dobbie H, Raffery MJ, Sheaff MT, Yagoob NM. Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombocytic microangiopathy. Am J transplant 2009:9:424-7.
DOI
ScienceOn
|
3 |
Baid S, Pascual M, Williams WW Jr, Tolkoff-Rubin N, Johnson SM, Collins B. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nepprol 1999;10:146-53.
|
4 |
Gallay BJ, Alpers CE, Davis CL, Schultz MF, Johnson RJ. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995;26:662-7.
DOI
ScienceOn
|
5 |
Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996;28:752-8.
DOI
ScienceOn
|
6 |
Chansirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009:4;345-53.
DOI
ScienceOn
|
7 |
Kwok SK, Ju JH, Cho CS, Kim HY, Park SH. Thrombotic thrombocytopenic purpura in systemic lupus erythema-tosus: risk factors and clinical outcome: a single center study. Lupus 2009;18:16-21.
DOI
|
8 |
Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:165-72.
DOI
ScienceOn
|
9 |
Hamasaki K, Miura T, Kanda H, Kubo K, Setoguchi K, Satoh T, et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 2003;22:355-8.
DOI
ScienceOn
|
10 |
Lansigan F, Isufi I, Tagoe CE. Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology 2011;50:824-9.
DOI
ScienceOn
|
11 |
Watanabe H, Kitagawa W, Suzuki K, Yoshino M, Aoyama R, Miura N, et al. Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Clin Exp Nephrol 2010;14:598-601.
DOI
|
12 |
Asamiya Y, Moriyama T, Takano M, Iwasaki C, Kimura K, Ando Y, et al. Successful treatment with Rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis. Inter Med 2010;49;1589-91.
|
13 |
Agrawal V, Vaidya CK, Ye J, Freeman J, McKiernan C, Blier PR, et al. Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent. Pediatr Nephrol 2011;26;1317-20.
DOI
|
14 |
Noda S, Ogura M, Tsutsumi A, Udagawa T, Kamei K, Matsuoka K, et al. Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome. Pediatr Nephrol 2012:27;681-5.
DOI
ScienceOn
|
15 |
McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apheresis. 2001; 16:202-9.
DOI
ScienceOn
|
16 |
Li PK, Lai FM, Tam JS, Lai KN. Acute renal failure due to postpartum hemolytic uremic syndrome. Aus N Z J Obstet Gynecol 1988;28:228-30.
DOI
ScienceOn
|
17 |
Mannucci PM, Canciani MT. Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor. Blood 2001;98: 2730-5.
DOI
ScienceOn
|
18 |
Furlan M, Lammle B. Aetology and pathogenesis of throm-botic thrombocytopenic purpura and hemolytic uremic syndrome. The role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 2001;14:437-54.
DOI
ScienceOn
|
19 |
Dragon-Durey M-A, Freneaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J Am Soc nephrol 2004;15:787-95.
DOI
ScienceOn
|
20 |
Kniaz D, Eisenberg GM, Elrad H, Johnson CA, Valatis J, Breqman H. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies: A case report and review of the literature. Am J Nephrol 1992;12:126-33.
DOI
|
21 |
Murgo AJ. Cancer and chemotherapy-associated thrmobotic microangiopathy, in Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura, Kaplan BS, Trom-peter RS, Moake JL, editors. New York; Marcel Dekker, Inc., 1992:271.
|
22 |
Remuzzi G, Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989;13:261-72.
DOI
|
23 |
Eremia V, Jefferson JA, Kowalewska JL, Hochster H, Haas M, Wisstuch J. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008:358;1129-36.
DOI
ScienceOn
|
24 |
Gurevich F, perazella MA. Renal effects of angiogenesis therapy: update for the internist. Am J Med 2009:122;322-8.
|
25 |
Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haematol 2009:102;371-8.
|
26 |
Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, et al. Ticlopidine and clopidogrel-associated thrombotic thrombocytopenic purpura(TTP); review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009;112;S20-S24.
|
27 |
Gottschall JL, Elliot W, Lianos E, McFarland JG, Wolfmeyer K, Aster RH. Quinine induced immune thrombocytopenia associated with hemolytic uremic syndrome: A new clinical entity. Blood 1991;77;306-10.
|
28 |
Fine DM, Fogo AB, Alpers CE. Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. Semin Nephrol 2008:28;545-55.
DOI
ScienceOn
|
29 |
Park YA, Waldrum MR, Marques MB. Platelet count and prothrombin time help distinguish thrombotic thrmobocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults. Am J Clin Pathol 2010; 133:460-5.
DOI
ScienceOn
|
30 |
Jenette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall's pathology of the kidney 6th ed. Philadelphia: Lippincott Williams & Wilkins. 2007;533-4 and 711-9.
|
31 |
Symmers WSC. Thrombotic microangiopathic hemolytic anemia(thrombotic microangiopathy). Br Med J 1952;2:897-903.
DOI
|
32 |
Gasser C, Gautier E, Steck A, Siebenmann Re, Oechslin R. Hamolytisch-uamische syndrome:Bilaterale Nierenrinden-nekrosen bei akuten erworbenen hamolytischen Anamien. Schweia Med Wochenschr 1955;85:905-9.
|
33 |
Habib R, Mathieu H, Royer P. Maladie thrombotique arteriolecapillaire du rein chez l'enf ant. Rev Fr Etud Clin Biol 1958; 3:891-4.
|
34 |
Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001;60:831-46.
DOI
ScienceOn
|
35 |
Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, et al. Acute neurological involvement in diar-rhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2010;5:1218-28.
DOI
ScienceOn
|
36 |
Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens 2010;19:242-7.
DOI
ScienceOn
|
37 |
Brunskill SJ, Tusold A, Benjamin S, Stanworth SJ, Murphy MF. A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Transfus Med 2007:17;17-35.
|
38 |
Nachman PH, Glassock RJ. Glomerular, vascular, and tubulointerstitial diseases. NephSAP 2008;7:185-9.
|
39 |
Espinosa G, Buccirelli S, Cervera R, Lozano M, Reverter J-C, de la Red G, et al. Thrombotic microangiopathic hemolytic anemia and antiphospholipid antibodies. Ann Rheum Dis 2004;63:730-6.
DOI
ScienceOn
|
40 |
Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura(TTP): can we differentiate one from the other?. Hypertens Res 2005;28:89-95.
DOI
ScienceOn
|